Search

Search Constraints

You searched for: Author/Creator Le May, Cédric

Search Results

2. Circulating PCSK9 levels are not associated with the conversion to type 2 diabetes. (January 2020)

3. Circulating PCSK9 levels are not associated with the severity of hepatic steatosis and NASH in a high-risk population. (November 2018)

4. Circulating Rather Than Intestinal PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Regulates Postprandial Lipemia in Mice. Issue 9 (September 2020)

5. Effects of proprotein convertase subtilisin kexin type 9 modulation in human pancreatic beta cells function. (June 2021)

6. Glycaemic control influences the relationship between plasma PCSK9 and LDL cholesterol in type 1 diabetes. Issue 3 (8th December 2016)

7. Identification of a Gain-of-Function LIPC Variant as a Novel Cause of Familial Combined Hypocholesterolemia. Issue 10 (28th July 2022)